GOLDMAN SACHS GROUP INC - SILVERBACK THERAPEUTICS INC ownership

SILVERBACK THERAPEUTICS INC's ticker is SBTX and the CUSIP is 82835W108. A total of 69 filers reported holding SILVERBACK THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
GOLDMAN SACHS GROUP INC ownership history of SILVERBACK THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$905,113
+9.7%
239,448
+94.4%
0.00%
Q2 2023$825,125
-35.5%
123,153
-37.3%
0.00%
Q1 2023$1,279,241
+32.8%
196,504
+74.1%
0.00%
Q4 2022$962,994
+83.1%
112,895
+13.3%
0.00%
Q3 2022$526,000
+0.6%
99,652
-19.2%
0.00%
Q2 2022$523,000
+46.5%
123,286
+21.2%
0.00%
Q1 2022$357,000
-31.5%
101,691
+30.0%
0.00%
Q4 2021$521,000
-4.1%
78,233
+43.9%
0.00%
Q3 2021$543,000
-86.7%
54,349
-38.1%
0.00%
-100.0%
Q4 2020$4,069,00087,8130.00%
Other shareholders
SILVERBACK THERAPEUTICS INC shareholders Q1 2021
NameSharesValueWeighting ↓
Nextech Invest Ltd. 1,910,029$10,085,0003.26%
K2 PRINCIPAL FUND, L.P. 3,247,533$16,890,0001.94%
SECTORAL ASSET MANAGEMENT INC 1,045,234$5,519,0001.09%
Orbimed Advisors 8,740,887$46,152,0000.86%
Rubric Capital Management LP 2,695,170$14,230,0000.72%
Prosight Management, LP 196,257$1,036,0000.56%
Nantahala Capital Management 1,249,863$6,599,0000.43%
Oasis Management Co Ltd. 317,662$1,677,0000.28%
TANG CAPITAL MANAGEMENT LLC 409,463$2,162,0000.26%
APOGEM CAPITAL LLC 13,793$73,0000.07%
View complete list of SILVERBACK THERAPEUTICS INC shareholders